Showing results (31-40 of 501) with videos related to
Sort By:
Pageof 51
Cellular Signalling|June 3, 2008
Domain-domain interaction of P-Rex1 is essential for the activation and inhibition by G protein betagamma subunits and PKADaisuke Urano, Asuka Nakata, Norikazu Mizuno, et al.American Journal of Audiology|March 15, 2017
Evaluation of Hearing Sensitivity in Young Adults With Normal Hearing Using a 40-Hz Auditory Steady-State Response With CE-ChirpHidehiko Maeda, Eiko Tamashige, Narumi Iwasaki, et al.Molecules (Basel, Switzerland)|April 13, 2024
Rearrangement of Arylsulfamates and Sulfates to Para-Sulfonyl Anilines and PhenolsYifei Zhou, Alan M JonesMolecules (Basel, Switzerland)|October 29, 2014
Diversity-oriented synthetic strategies applied to cancer chemical biology and drug discoveryIan Collins, Alan M JonesPlos One|September 2, 2025
Observational suspected adverse drug reaction profiles of fluoro-pharmaceuticals and potential mimicry of per- and polyfluoroalkyl substances (PFAS) in the United KingdomBanurja Balasubramaniam, Alan M JonesBritish Journal of Clinical Pharmacology|May 19, 2022
Angiotensin II receptor blockers (ARBs) and manufacturing contamination: A retrospective National Register Study into suspected associated adverse drug reactionsHamisha Salim, Alan M JonesPlant Signaling & Behavior|August 21, 2010
NDR proteins: lessons learned from Arabidopsis and animal cells prompt a testable hypothesisYashwanti Mudgil, Alan M JonesPharmacology Research & Perspectives|December 5, 2022
Suspected adverse drug reactions of the type 2 antidiabetic drug class dipeptidyl-peptidase IV inhibitors (DPP4i): Can polypharmacology help explain?Lauren Jones, Alan M JonesMolecules (Basel, Switzerland)|April 13, 2024
A General Method to Access Underexplored Ylideneamino Sulfates as Interrupted Beckmann-Type Rearrangement IntermediatesYifei Zhou, Alan M JonesPageof 51